COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,189 Articles (22,713 medRxiv, 8,476 bioRxiv)

Most recent first Previous |  Page 1017: Articles 10161-10170  | Next

Humoral immune responses against SARS-CoV-2 variants including omicron in solid organ transplant recipients after three doses of a COVID-19 mRNA vaccine
Saharia, K. K., Husson, J. S., Niederhaus, S. V., Iraguha, T., Avila, S. V., Yoo, Y. J., Hardy, N. M., Fan, X., Omili, D., Crane, A., Carrier, A., Xie, W. Y., Vander Mause, E., Hankey, K., Bauman, S., Lesho, P., Mannuel, H. D., Ahuja, A., Mathew, M., Avruch, J., Baddley, J., Goloubeva, O., Shetty, K., Dahiya, S., Rapoport, A. P., Luetkens, T., Atanackovic, D.
10.1101/2021.12.29.21268529 — Posted: 2022-01-01
Early signals of significantly increased vaccine breakthrough, decreased hospitalization rates, and less severe disease in patients with COVID-19 caused by the Omicron variant of SARS-CoV-2 in Houston, Texas
Christensen, P. A., Olsen, R. J., Long, S. W., Snehal, R., Davis, J. J., Ojeda Saavedra, M., Reppond, K., Shyer, M. N., Cambric, J., Gadd, R., Thakur, R. M., Batajoo, A., Mangham, R., Pena, S., Trinh, T., Kinskey, J. C., Williams, G., Olson, R., Golihar, J., Musser, J. M.
10.1101/2021.12.30.21268560 — Posted: 2022-01-01 Discussion: Onsite
A Web-based Spatial Decision Support System of Wastewater Surveillance for COVID-19 Monitoring: A Case Study of a University Campus
Tang, W., Chen, T., Slocum, Z., Lan, Y., Delmelle, E., Chen, D., Mittal, N., Rice-Boayue, J., Shuka, T., Lin, S., Akella, S., Schlueter, J., Munir, M., Gibas, C. J.
10.1101/2021.12.29.21268516 — Posted: 2022-01-01
Sample Size Calculations for Variant Surveillance in the Presence of Biological and Systematic Biases
Wohl, S., Lee, E. C., DiPrete, B. L., Lessler, J.
10.1101/2021.12.30.21268453 — Posted: 2022-01-01
Inferring effects of mutations on SARS-CoV-2 transmission from genomic surveillance data
Lee, B., Sohail, M. S., Finney, E., Ahmed, S. F., Quadeer, A. A., McKay, M. R., Barton, J. P.
10.1101/2021.12.31.21268591 — Posted: 2022-01-01
Increased Risk of Poor Clinical Outcome in COVID-19 Patients with Diabetes Mellitus and in-hospital Mortality Predictors: A Retrospective Cohort from a Tertiary Hospital in Indonesia
Mokoagow, M. I., Saksono Harbuwono, D., Kshanti, I. A., Rumende, C. M., Subekti, I., Harimurti, K., Lie, K. C., Shatri, H.
10.1101/2021.12.30.21266217 — Posted: 2022-01-01
Endothelin-1 is Increased in the Plasma of Patients Hospitalized with Covid-19
Abraham, G., Kuc, R., Althage, M., Greasley, P., Ambery, P., Maguire, J., Wilkinson, I., Hoole, S., Cheriyan, J., Davenport, A.
10.1101/2021.12.30.21268236 — Posted: 2022-01-01
Cross reactivity of spike glycoprotein induced antibody against delta and omicron variants before and after third SARS-CoV-2 vaccine dose
Faustini, S. E., Shields, A. M., Banham, G., Wall, N., Al-Taei, S., Tanner, C., Ahmed, Z., Efstathiou, E., Townsend, N., Price, R., Curry, G., Robertson, L., Nesbit, A., Black, A., MOORE, J., McLaughlin, J., Farnan, J., COVID-HD Birmingham Study Group, , PITCH consortium, , Cunningham, A. F., Harper, L., Moore, T., Drayson, M. T., Richter, A. G.
10.1101/2021.12.30.21268308 — Posted: 2022-01-01
EARLY LENZILUMAB TREATMENT OF COVID-19 PATIENTS USING C-REACTIVE PROTEIN AS A BIOMARKER IMPROVES EFFICACY: RESULTS FROM THE PHASE 3 LIVE-AIR TRIAL
Temesgen, Z., Kelley, C. F., Cerasoli, F., Kilcoyne, A., Chappell, D., Durrant, C., Ahmed, O., Chappell, G., Catterson, V., Polk, C., Badley, A. D., Marconi, V., the LIVE-AIR Study Group
10.1101/2021.12.30.21267140 — Posted: 2022-01-01
Viral cultures, PCR Cycle threshold values and viral load estimation for COVID-19 infectious potential assessment in transplant patients: systematic review - Protocol Version 29 December 2021
Jefferson, T., Spencer, E. A., Maltoni, S., Brassey, J., ONAKPOYA, I., Rosca, E. C., Pludderman, A., Evans, D., Conly, J., Heneghan, C.
10.1101/2021.12.30.21268509 — Posted: 2022-01-01

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).